NACC1 and neoplasm: In addition, to our knowledge, this study is the first report to prove the prognostic impact of the NAC1/ACOX2 axis; high levels of NAC1 combined with low levels of ACOX2 were associated with worse prognosis in patients with ERONs, signifying a novel prognostic marker for this tumor type.